Silent thyroiditis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Furqan M Muhammad (talk | contribs)
nocaptcha
5,074 edits
No edit summary
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Bot: Removing from Primary care
 
(16 intermediate revisions by 2 users not shown)
Line 4: Line 4:
{{CMG}}; {{AE}} {{MMF}}
{{CMG}}; {{AE}} {{MMF}}
==Overview==
==Overview==
Silent thyroiditis is a rare disease with the [[incidence]] of up to 23000 per 100,000 individuals with [[hyperthyroidism]]. The [[prevalence]] of silent thyroiditis is approximately 1000 per 100,000 individuals with [[thyrotoxicosis]]. Silent thyroiditis commonly affects patients in 30-40 years of age. Females are more commonly affected by silent thyroiditis than males. The female to male ratio is approximately 4 to 1. Silent thyroiditis is more common in areas of higher dietary [[iodine]] intake.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
The incidence of silent thyroiditis is up to 23000 per 100,000 individuals with [[hyperthyroidism]].<ref name="pmid6892676">{{cite journal |vauthors=Nikolai TF, Brosseau J, Kettrick MA, Roberts R, Beltaos E |title=Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis) |journal=Arch. Intern. Med. |volume=140 |issue=4 |pages=478–82 |year=1980 |pmid=6892676 |doi= |url=}}</ref><ref name="pmid3720149">{{cite journal |vauthors=Schorr AB, Miller JL, Shtasel P, Rose LI |title=Low incidence of painless thyroiditis in the Philadelphia area |journal=Clin Nucl Med |volume=11 |issue=6 |pages=379–80 |year=1986 |pmid=3720149 |doi= |url=}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
===Prevalence===
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
The prevalence of silent thyroiditis is approximately 1000 per 100,000 individuals with [[thyrotoxicosis]].<ref name="pmid9534035">{{cite journal |vauthors=Ross DS |title=Syndromes of thyrotoxicosis with low radioactive iodine uptake |journal=Endocrinol. Metab. Clin. North Am. |volume=27 |issue=1 |pages=169–85 |year=1998 |pmid=9534035 |doi= |url=}}</ref><ref name="pmid12826640">{{cite journal |vauthors=Pearce EN, Farwell AP, Braverman LE |title=Thyroiditis |journal=N. Engl. J. Med. |volume=348 |issue=26 |pages=2646–55 |year=2003 |pmid=12826640 |doi=10.1056/NEJMra021194 |url=}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
*The case-fatality rate of [disease name] is approximately [number range].
===Age===
===Age===
*Patients of all age groups may develop [disease name].
Silent thyroiditis commonly affects patients in 30-40 years of age.<ref name="pmid22443972">{{cite journal |vauthors=Samuels MH |title=Subacute, silent, and postpartum thyroiditis |journal=Med. Clin. North Am. |volume=96 |issue=2 |pages=223–33 |year=2012 |pmid=22443972 |doi=10.1016/j.mcna.2012.01.003 |url=}}</ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
There is no racial predilection to silent thyroiditis.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*[Disease name] affects men and women equally.
Females are more commonly affected by silent thyroiditis than males. The female to male ratio is approximately 4 to 1.<ref name="pmid12826640">{{cite journal |vauthors=Pearce EN, Farwell AP, Braverman LE |title=Thyroiditis |journal=N. Engl. J. Med. |volume=348 |issue=26 |pages=2646–55 |year=2003 |pmid=12826640 |doi=10.1056/NEJMra021194 |url=}}</ref>
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
===Region===
*The majority of [disease name] cases are reported in [geographical region].
Silent thyroiditis is more common in areas of higher dietary [[iodine]] intake. It is more common in the great lakes area of North America and Japan.<ref name="pmid22443972">{{cite journal |vauthors=Samuels MH |title=Subacute, silent, and postpartum thyroiditis |journal=Med. Clin. North Am. |volume=96 |issue=2 |pages=223–33 |year=2012 |pmid=22443972 |doi=10.1016/j.mcna.2012.01.003 |url=}}</ref><ref name="pmid3838433">{{cite journal |vauthors=Vitug AC, Goldman JM |title=Silent (painless) thyroiditis. Evidence of a geographic variation in frequency |journal=Arch. Intern. Med. |volume=145 |issue=3 |pages=473–5 |year=1985 |pmid=3838433 |doi= |url=}}</ref>
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===
 
 


==References==
==References==
Line 48: Line 30:
{{WS}}
{{WS}}


[[Category:Disease]]
​
[[Category:Endocrinology]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Up-To-Date]]

Latest revision as of 00:11, 30 July 2020

Silent thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Silent thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Silent thyroiditis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Silent thyroiditis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Silent thyroiditis epidemiology and demographics

CDC on Silent thyroiditis epidemiology and demographics

Silent thyroiditis epidemiology and demographics in the news

Blogs on Silent thyroiditis epidemiology and demographics

Directions to Hospitals Treating Silent thyroiditis

Risk calculators and risk factors for Silent thyroiditis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]

Overview

Silent thyroiditis is a rare disease with the incidence of up to 23000 per 100,000 individuals with hyperthyroidism. The prevalence of silent thyroiditis is approximately 1000 per 100,000 individuals with thyrotoxicosis. Silent thyroiditis commonly affects patients in 30-40 years of age. Females are more commonly affected by silent thyroiditis than males. The female to male ratio is approximately 4 to 1. Silent thyroiditis is more common in areas of higher dietary iodine intake.

Epidemiology and Demographics

Incidence

The incidence of silent thyroiditis is up to 23000 per 100,000 individuals with hyperthyroidism.[1][2]

Prevalence

The prevalence of silent thyroiditis is approximately 1000 per 100,000 individuals with thyrotoxicosis.[3][4]

Age

Silent thyroiditis commonly affects patients in 30-40 years of age.[5]

Race

There is no racial predilection to silent thyroiditis.

Gender

Females are more commonly affected by silent thyroiditis than males. The female to male ratio is approximately 4 to 1.[4]

Region

Silent thyroiditis is more common in areas of higher dietary iodine intake. It is more common in the great lakes area of North America and Japan.[5][6]

References

  1. ↑ Nikolai TF, Brosseau J, Kettrick MA, Roberts R, Beltaos E (1980). "Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis)". Arch. Intern. Med. 140 (4): 478–82. PMID 6892676.
  2. ↑ Schorr AB, Miller JL, Shtasel P, Rose LI (1986). "Low incidence of painless thyroiditis in the Philadelphia area". Clin Nucl Med. 11 (6): 379–80. PMID 3720149.
  3. ↑ Ross DS (1998). "Syndromes of thyrotoxicosis with low radioactive iodine uptake". Endocrinol. Metab. Clin. North Am. 27 (1): 169–85. PMID 9534035.
  4. ↑ 4.0 4.1 Pearce EN, Farwell AP, Braverman LE (2003). "Thyroiditis". N. Engl. J. Med. 348 (26): 2646–55. doi:10.1056/NEJMra021194. PMID 12826640.
  5. ↑ 5.0 5.1 Samuels MH (2012). "Subacute, silent, and postpartum thyroiditis". Med. Clin. North Am. 96 (2): 223–33. doi:10.1016/j.mcna.2012.01.003. PMID 22443972.
  6. ↑ Vitug AC, Goldman JM (1985). "Silent (painless) thyroiditis. Evidence of a geographic variation in frequency". Arch. Intern. Med. 145 (3): 473–5. PMID 3838433.

Template:WH Template:WS

​

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Silent_thyroiditis_epidemiology_and_demographics&oldid=1643336"